A study on the mycobacterial burden and phenotypic drug resistance pattern with reference to the GeneXpert Cycle Threshold values in pulmonary tuberculosis
Open Access
- 30 December 2023
- journal article
- research article
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 21 (4) , 730-735
Abstract
Introduction and aim. Tuberculosis (TB) remains a significant global health challenge. Early and accurate diagnosis is crucial to prevent further transmission. The present study aimed to correlate cycle threshold values with smear microscopy and culture positivity, and determine cut-off cycle threshold values for levels of smear grade and culture positivity. Material and methods. Forty presumptive cases of pulmonary TB were included and subjected to Ziehl- Neelsen stain, culture on Lowenstein Jensen media, CBNAAT and drug susceptibility testing for first line anti-tubercular drugs. Results. Our study predicts 3+, 2+, and 1+ sputum smear grade at a cut-off of Ct value ≤ 16.74, ≤19.68, and ≤ 22.32 respectively. A strong positive correlation was found between time to culture positivity and Ct value. A cut-off of Ct value ≤22.32 predicts culture positivity with a sensitivity of 92%, and a specificity of 67%. None of the isolates showed rifampicin resistance by 1% proportion method. Conclusion. Understanding the appropriate utilization of CBNAAT Ct values and their correlation with smear microscopy grade, culture, and drug susceptibility testing can assist clinicians in early identification and prompt initiation of appropriate treatment. This knowledge can contribute to the prevention of drug resistance, reduced transmission, and a decreased disease burden associated with TB.Keywords
This publication has 13 references indexed in Scilit:
- Sputum smear grading and associated factors among bacteriologically confirmed pulmonary drug-resistant tuberculosis patients in EthiopiaBMC Infectious Diseases, 2021
- Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional studyPLOS ONE, 2019
- The value of xpert MTB/RIF-generated CT values for predicting the smear status of patients with pulmonary tuberculosisJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2018
- The clinical utility of cycle of threshold value of GeneXpert MTB/RIF (CBNAAT) and its diagnostic accuracy in pulmonary and extra-pulmonary samples at a tertiary care center in IndiaIndian Journal of Tuberculosis, 2018
- Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern AfricaScientific Reports, 2018
- Clinical challenges in the era of multiple and extensively drugresistant tuberculosisRevista Panamericana de Salud Pública, 2017
- Current tools available for the diagnosis of drug-resistant tuberculosisTherapeutic Advances in Infectious Disease, 2016
- Xpert ® MTB/RIF Assay: Development, Evaluation and Implementation of a New Rapid Molecular Diagnostic for Tuberculosis and Rifampicin ResistanceFuture Microbiology, 2011
- Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2006
- Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification testDiagnostic Microbiology and Infectious Disease, 2005